Vertex Pharmaceuticals (BSP:VRTX34) Inventories, Raw Materials & Components : R$386 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Vertex Pharmaceuticals Inventories, Raw Materials & Components?

Vertex Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Dec. 2023 was R$386 Mil.

Vertex Pharmaceuticals's quarterly raw materials increased from Jun. 2023 (R$348 Mil) to Sep. 2023 (R$383 Mil) and increased from Sep. 2023 (R$383 Mil) to Dec. 2023 (R$386 Mil).

Vertex Pharmaceuticals's annual raw materials declined from Dec. 2021 (R$240 Mil) to Dec. 2022 (R$200 Mil) but then increased from Dec. 2022 (R$200 Mil) to Dec. 2023 (R$386 Mil).

Vertex Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Vertex Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vertex Pharmaceuticals Inventories, Raw Materials & Components Chart

Vertex Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

107.73

237.69

239.77

199.85

385.61

Vertex Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															199.85	302.62	348.50	382.75	385.61

Vertex Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Vertex Pharmaceuticals (BSP:VRTX34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (BSP:VRTX34) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

VRTX:USA VRTX:Mexico 1VRTX:Italy VX1d:UK VX1:Germany VRTX:Austria

Address

50 Northern Avenue, Boston, MA, USA, 02210

Website

https://www.vrtx.com

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Vertex Pharmaceuticals (BSP:VRTX34) Headlines

No Headlines